223 related articles for article (PubMed ID: 33399225)
1. Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists.
Hopkins PM; Girard T; Dalay S; Jenkins B; Thacker A; Patteril M; McGrady E
Anaesthesia; 2021 May; 76(5):655-664. PubMed ID: 33399225
[TBL] [Abstract][Full Text] [Related]
2. Malignant hyperthermia.
Ben Abraham R; Adnet P; Glauber V; Perel A
Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
[TBL] [Abstract][Full Text] [Related]
3. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
[TBL] [Abstract][Full Text] [Related]
4. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
Haugen T; Toft M; Müller CR; Aasly J
Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
[TBL] [Abstract][Full Text] [Related]
5. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
Glahn KPE; Bendixen D; Girard T; Hopkins PM; Johannsen S; Rüffert H; Snoeck MM; Urwyler A;
Br J Anaesth; 2020 Aug; 125(2):133-140. PubMed ID: 32591088
[TBL] [Abstract][Full Text] [Related]
6. Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
Nishiyama K; Kitahara A; Natsume H; Matsushita A; Nakano K; Sasaki S; Genma R; Yamamoto Y; Nakamura H
Endocr J; 2001 Apr; 48(2):227-32. PubMed ID: 11456272
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and Treatment of Malignant Hyperthermia.
Gregory H; Weant KA
Adv Emerg Nurs J; 2021 Apr-Jun 01; 43(2):102-110. PubMed ID: 33915557
[TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia.
Ali SZ; Taguchi A; Rosenberg H
Best Pract Res Clin Anaesthesiol; 2003 Dec; 17(4):519-33. PubMed ID: 14661655
[TBL] [Abstract][Full Text] [Related]
9. [Malignant hyperthermia].
Bouhajja B; Haddad F; Ben Ammar MS
Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
[TBL] [Abstract][Full Text] [Related]
10. A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis.
Green G
Acta Anaesthesiol Scand; 2003 May; 47(5):619-21. PubMed ID: 12699524
[TBL] [Abstract][Full Text] [Related]
11. Malignant hyperthermia in the otology patient: the UCLA experience.
Wackym PA; Blackwell KE
Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of malignant hyperthermia crisis during anesthesia].
Amiel I; Nivoche Y
Ann Fr Anesth Reanim; 1989; 8(5):427-34. PubMed ID: 2697157
[TBL] [Abstract][Full Text] [Related]
13. [Malignant hyperthermia].
Zimprich F; Kress HG; Zeitlhofer J
Wien Klin Wochenschr; 2003 Sep; 115(15-16):556-62. PubMed ID: 14531168
[TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia.
Halliday NJ
J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
[TBL] [Abstract][Full Text] [Related]
16. Malignant hyperthermia: considerations for the general surgeon.
Heggie JE
Can J Surg; 2002 Oct; 45(5):369-72. PubMed ID: 12387544
[TBL] [Abstract][Full Text] [Related]
17. Successful Treatment Without Using Dantrolene Sodium on a Child Occurring Malignant Hyperthermia During Induction of General Anesthesia: A Case Report.
Zheng Q; Liu N; Zeng Y; Chen Y; Zhang H; Su X; Zhuang J
J Craniofac Surg; 2024 Jun; 35(4):e351-e354. PubMed ID: 38829149
[TBL] [Abstract][Full Text] [Related]
18. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Ward A; Chaffman MO; Sorkin EM
Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
[TBL] [Abstract][Full Text] [Related]
19. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
[TBL] [Abstract][Full Text] [Related]
20. [Malignant hyperthermia].
Chastonay P; Bracco D; Freymond D; Ravussin P
Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
